Biofrontera (BFRI) Amortization of Deferred Charges (2020 - 2025)

Biofrontera's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $366000.0 for Q4 2025.

• On a quarterly basis, Amortization of Deferred Charges fell 23.75% year-over-year to $366000.0 in Q4 2025; TTM through Dec 2025 was $730000.0, a 0.27% change from a year earlier, with the FY2025 full-year figure at $730000.0, changed 0.27% from the prior year.
• Amortization of Deferred Charges climbed to $366000.0 in Q4 2025 per BFRI's latest filing, from -$22000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $480000.0 in Q4 2024 and bottomed at -$22000.0 in Q3 2025.
• The 5-year median for Amortization of Deferred Charges is $90000.0 (2021), against an average of $151450.0.
• Across the five-year window, Amortization of Deferred Charges soared 327.78% in 2022 and tumbled 1200.0% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $90000.0 in 2021, then surged by 327.78% to $385000.0 in 2022, then tumbled by 31.43% to $264000.0 in 2023, then surged by 81.82% to $480000.0 in 2024, then fell by 23.75% to $366000.0 in 2025.
• Per Business Quant, the three latest BFRI Amortization of Deferred Charges figures stand at $366000.0 (Q4 2025), -$22000.0 (Q3 2025), and $267000.0 (Q2 2025).